Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 inpatients with chronic lymphocytic leukemia

Autor: Stéphanie Malartre, Cristina Bagacean, Véronique Leblond, Aline Clavert, Hugo Legendre, Caroline Dartigeas, Nanthara Sritharan, Bernard Drenou, Kamel Laribi, Xavier Troussard, Ségolène Brichler, Anne-Sophie Michallet, Driss Chaoui, Alain Delmer, Lise Willems, Christian Puppinck, Cécile Tomowiak, Fatiha Merabet, Damien Roos-Weil, Chadi Al-Nawakil, Florence Cymbalista, Rémi Letestu, Marie C. Béné, Romain Guieze, Vincent Levy, Philippe Genet

Publikováno v: Blood Advances
Blood Advances, The American Society of Hematology, 2022, 6 (1), pp.207-211. ⟨10.1182/bloodadvances.2021006215⟩

Immunocompromised individuals such as patients with chronic lymphocytic leukemia (CLL) are at risk of impaired immune responses to vaccination. The objective of our study was to evaluate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8f6ff29fe1b1f71f722a373e71a0ebd
http://europepmc.org/articles/PMC8632355

Old DAT and new data: Positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients

Autor: Anne Quinquenel, Nadine Varin-Blank, Vincent Levy, Chadi Al Nawakil, Fanny Baran-Marszak, Virginie Eclache, Christine Le Roy, Florence Ajchenbaum-Cymbalista, Rémi Letestu, Alain Delmer, Mohammed Khalloufi, Marouane Boubaya

Publikováno v: American Journal of Hematology. 90:E5-E8

Only a minority of chronic lymphocytic leukemia (CLL) patients harboring a positive direct antiglobulin test (DAT) will develop autoimmune hemolytic anemia (AIHA). In a single institution cohort of 378 CLL patients, 56 patients (14.8%) had at least o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6da6072106dea654a6b140f62706a475
https://doi.org/10.1002/ajh.23861

Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study

Autor: Francois Xavier Goudot, Loic Ysebaert, Constantine S. Tam, Vincent Levy, Jehan Dupuis, Chadi Al Nawakil, Anne Quinquenel, Marie Sarah Dilhuydy, Eric Van Den Neste, Christophe Meune, Philip A. Thompson, Anne Sophie Michallet, Florence Cymbalista, Michael J. Keating

Publikováno v: British journal of haematology. 175(3)

Summary Atrial fibrillation (AF) occurs in 5–9% of patients treated with ibrutinib for chronic lymphocytic leukaemia (CLL); the clinical consequences and optimal management are unclear. We retrospectively studied 56 CLL patients who received ibruti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98abcefb8bc509eca61627ca948afdbc
https://pubmed.ncbi.nlm.nih.gov/27611114

Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients

Autor: Catherine Thieblemont, Marjane Ertault, Patricia Franchi, Cédric de Bazelaire, Eric de Kerviler, Josette Brière, Nathalie Beranger, Chadi Al Nawakil, Pauline Brice, David Sibon

Publikováno v: British Journal of Haematology. 153:191-198

Summary Around 20% of Hodgkin lymphoma (HL) patients are refractory to first-line therapy with ABVD (adriamycin–bleomycin–vinblastine–dacarbazine) or relapse after complete remission. Salvage regimens frequently have delayed courses or require

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4c29c00389af048241d6422460c03ffc
https://doi.org/10.1111/j.1365-2141.2011.08594.x

Salvage therapy of Autoimmune Thrombocytopenic Purpura revealing non-Hodgkin Lymphoma by the thrombopoietin receptor agonist romiplostim

Autor: Thierry Jo Molina, Olivier Hermine, Didier Bouscary, T.-A. Szwebel, Jerome Tamburini, Francois Dreyfus, Laure Gibault, Nicolas Chapuis, Chadi Al-Nawakil, Sophie Park

Publikováno v: British Journal of Haematology. 156:145-147

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d942c921388ae98baace42423dfe17f
https://doi.org/10.1111/j.1365-2141.2011.08825.x